Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation

New England Journal of Medicine

Volumn 345, Issue 3, 2001, Pages 159-164

  Meijers Heijboer, Hanne ^a   Van Geel, Bert ^a   Van Putten, Wim L J ^a   Henzen Logmans, Sonja C ^a   Seynaeve, Caroline ^a   Menke Pluymers, Marian B E ^a   Bartels, Carina C M ^a   Verhoog, Leon C ^a   Van Den Ouweland, Ans M W ^a   Niermeijer, Martinus F ^a   Brekelmans, Cecile T M ^a   Klijn, Jan G M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER PREVENTION; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; ONCOGENE; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADULT; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; HUMANS; MASTECTOMY, SIMPLE; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; TRANSCRIPTION FACTORS;

EID: 0035913275     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200107193450301     Document Type: Article

References (33)

1. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
2. Identification of the breast cancer susceptibility gene BRCA2
3. BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision making and outcomes
4. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation
5. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
6. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
7. Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1
8. Survival in hereditary breast cancer associated with germline mutations of BRCA2
9. Should prophylactic surgery be used in women with a high risk of breast cancer?
10. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2
11. The women at increased risk for breast cancer: Evaluation and management strategies
12. Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer
13. Rapid detection of BRCA1 mutations by the protein truncation test
14. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients
15. Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families
16. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: Results from three U.S. population-based case-control studies of ovarian cancer
17. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer
18. Bilateral prophylactic mastectomy (PM) in BRCA1/2 mutation carriers
19. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk
20. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: Preliminary results
21. MRI screening for breast cancer in women with high familial risk
22. Prophylactic mastectomy: Pathologic findings in high-risk patients
23. Inheritance of proliferative breast disease in breast cancer kindreds
24. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers
25. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
26. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: A case-control study
27. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer
28. Complications leading to surgery after breast implantation
29. Surgical morbidities following bilateral prophylactic mastectomy
30. Predictors of and satisfaction with bilateral prophylactic mastectomy
31. Patient regrets after bilateral prophylactic mastectomy
32. Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy
33. The psychosocial impact of bilateral prophylactic mastectomy: Prospective study using questionnaires and semistructured interviews